| APLN | Apelin |
| AUA | American Urological Association |
| AUC | Area under the ROC curve |
| BCL9 | B-cell CLL/lymphoma 9 |
| BCR | Biochemical recurrence |
| BPH | Benign prostatic hyperplasia |
| CoxM | Multivariate Cox regression analysis |
| CoxU | Univariate Cox regression analysis |
| EAU | European Association of Urology |
| FFPE | Formalin-fixed, paraffin-embedded |
| HR | Hazard ratio |
| ISUP | International Society of Urological Pathology |
| KMA | Kaplan-Meier analysis |
| MeSH | Medical Subject Heading of the U.S. National Library of Medicine |
| miQ | miRNA index quote |
| MIQE | Minimum information for publication of quantitative real-time PCR experiments |
| miRNA, miR | microRNA |
| MW | Mann-Whitney U-test |
| MYPT1 | Protein phosphatase 1 regulatory subunit 12A (official symbol: PPP1R12A) |
| PCa | Prostate carcinoma |
| PSA | Prostate-specific antigen |
| RB1CC1 | RB1 inducible coiled-coil 1 |
| REMARK | Reporting Recommendations for Tumor Marker Prognostic Studies |
| RFS | Biochemical recurrence-free survival |
| RM | Reference method, in general the reference gene |
| ROC | Receiver-operating characteristic curve |
| ROCK1 | Rho associated coiled-coil containing protein kinase 1 |
| RP | Radical prostatectomy |
| RT-qPCR | Reverse transcription-quantitative polymerase chain reaction |
| SOCS | Cytokine inducible SH2 containing protein (official symbol: CISH) |
| STARD | Standards for Reporting of Diagnostic Accuracy |
| TCGA | The Cancer Genome Atlas |
| TNM | Classification of malignant tumors describing the involment of the primary tumor, regional lymph nodes and the distant metastatic spread |
| TRIB1 | Tribbles pseudokinase 1 |